A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment
DOI10.1016/J.JTBI.2014.11.021zbMATH Open1412.92178OpenAlexW2036084890WikidataQ28649754 ScholiaQ28649754MaRDI QIDQ2415779FDOQ2415779
Authors: E. Pienaar, Nicholas A. Cilfone, Philana Ling Lin, Véronique Dartois, Joshua T. Mattila, J. Butler, Joanne Flynn, Denise E. Kirschner, Jennifer J. Linderman 
Publication date: 23 May 2019
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2014.11.021
Recommendations
- A population model capturing dynamics of tuberculosis granulomas predicts host infection outcomes
- Mathematical modeling of pulmonary tuberculosis therapy: insights from a prototype model with rifampin
- Mathematical modeling and systems pharmacology of tuberculosis: isoniazid as a case study
- Identifying control mechanisms of granuloma formation during \textit{M. tuberculosis} infection using an agent-based model
- A virtual host model of \textit{Mycobacterium tuberculosis} infection identifies early immune events as predictive of infection outcomes
Medical epidemiology (92C60) Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45)
Cites Work
- Title not available (Why is that?)
- A methodology for performing global uncertainty and sensitivity analysis in systems biology
- On the optimality of the simple Bayesian classifier under zero-one loss
- Mathematical modeling of pulmonary tuberculosis therapy: insights from a prototype model with rifampin
- Identifying control mechanisms of granuloma formation during \textit{M. tuberculosis} infection using an agent-based model
- Fast Fourier transform method for partial differential equations, case study: The 2-D diffusion equation
- A model of isoniazid treatment of tuberculosis
Cited In (6)
- Modeling basic aspects of bacterial resistance of Mycobacterium tuberculosis to antibiotics
- Modeling nanoparticle delivery of TB drugs to granulomas
- Mathematical modeling and systems pharmacology of tuberculosis: isoniazid as a case study
- Mathematical modeling of pulmonary tuberculosis therapy: insights from a prototype model with rifampin
- Modelling the effects of environmental heterogeneity within the lung on the tuberculosis life-cycle
- A pipeline for testing drug mechanism of action and combination therapies: from microarray data to simulations via linear-in-flux-expressions. Testing four-drug combinations for tuberculosis treatment
This page was built for publication: A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2415779)
